These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8914059)

  • 1. Amino acid-based peritoneal dialysis solutions.
    Faller B
    Kidney Int Suppl; 1996 Nov; 56():S81-5. PubMed ID: 8914059
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of dialysis solutions containing amino acids on the nutritional status of patients treated with continuous ambulatory peritoneal dialysis].
    Opatrná S; Liska J; Vít L; Hostasová A; Opatrný K
    Cas Lek Cesk; 1997 Jun; 136(13):409-12. PubMed ID: 9333515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino-acid-based dialysis solution changes leptinemia and leptin peritoneal clearance.
    Grzegorzewska AE; Wiecek A; Mariak I; Kokot F
    Adv Perit Dial; 2000; 16():7-14. PubMed ID: 11045252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic intraperitoneal administration of amino acids does not improve the nutritional status of malnourished continuous ambulatory peritoneal dialysis patients.
    Dombros NV
    Perit Dial Int; 1993; 13 Suppl 2():S487-90. PubMed ID: 8399647
    [No Abstract]   [Full Text] [Related]  

  • 5. Low or high calcium dialysate solutions in peritoneal dialysis?
    Weinreich T
    Kidney Int Suppl; 1996 Nov; 56():S92-6. PubMed ID: 8914061
    [No Abstract]   [Full Text] [Related]  

  • 6. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM; Struijk DG; Smit W; Krediet RT
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid.
    Yang SY; Huang JW; Shih KY; Hsu SP; Chu PL; Chu TS; Wu KD
    Nephrol Dial Transplant; 2005 Jan; 20(1):161-6. PubMed ID: 15572386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of malnutrition in peritoneal dialysis patients].
    Lobbedez T; Pujo M; el Haggan W; Hurault de Ligny B; Levaltier B; Ryckelynck JP
    Nephrologie; 2003; 24(7):387-9. PubMed ID: 14650752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resumption of peritoneal dialysis after transcutaneous treatment of a peritoneal leakage using fibrin glue.
    Herbrig K; Pistrosch F; Gross P; Palm C
    Nephrol Dial Transplant; 2006 Jul; 21(7):2037-8. PubMed ID: 16520352
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction of peritoneal membrane permeability by long-term use of neutral-pH peritoneal dialysis solution: a preliminary report in high transporters.
    Kuriyama S; Otsuka Y; Iida R; Kobayashi S; Yamagishi H; Hosoya T
    Clin Exp Nephrol; 2004 Dec; 8(4):392-3. PubMed ID: 15619044
    [No Abstract]   [Full Text] [Related]  

  • 11. Amino acid dialysate.
    Goodship TH; Arfeen S; Kirkwood A; Wilkinson R; Ward MK
    Contrib Nephrol; 1990; 85():84-91. PubMed ID: 2078943
    [No Abstract]   [Full Text] [Related]  

  • 12. Value of intraperitoneal amino acids in children treated with chronic peritoneal dialysis.
    Canepa A; Verrina E; Perfumo F; Carrea A; Menoni S; Delucchi P; Gusmano R
    Perit Dial Int; 1999; 19 Suppl 2():S435-40. PubMed ID: 10406560
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biocompatibility of dialysis fluid in peritoneal dialysis--limitations and possibilities of improvement].
    Olszowska A; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):364-7. PubMed ID: 18634375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility of peritoneal dialysis fluid and influence of compositions on peritoneal fibrosis.
    Higuchi C; Nishimura H; Sanaka T
    Ther Apher Dial; 2006 Aug; 10(4):372-9. PubMed ID: 16911191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peritoneal dialysis].
    Ryckelynck JP; Lobbedez T; Hurault de Ligny B
    Nephrol Ther; 2005 Oct; 1(4):252-63. PubMed ID: 16895693
    [No Abstract]   [Full Text] [Related]  

  • 16. Fasting plasma amino acids are not normalized by 12-month amino acid-based dialysate in CAPD patients.
    Jones CH; Smith M; Henderson MJ; Will EJ; Davison AM; Newstead CG
    Perit Dial Int; 1999; 19(2):174-7. PubMed ID: 10357192
    [No Abstract]   [Full Text] [Related]  

  • 17. [Composition of amino acid in blood and dialysate by patients with in chronic renal insufficiency by peritoneal dialysis].
    Pichugina IS; Gapparov MM; Chukarina EV; Vetchinnikova ON; Vatazin AV
    Vopr Pitan; 2008; 77(3):45-8. PubMed ID: 18669331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental peritoneal dialysis solutions.
    Martis L; Holmes C; Shockley T
    Perit Dial Int; 1993; 13 Suppl 2():S98-100. PubMed ID: 8399683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis.
    Tjiong HL; van den Berg JW; Wattimena JL; Rietveld T; van Dijk LJ; van der Wiel AM; van Egmond AM; Fieren MW; Swart R
    J Am Soc Nephrol; 2005 May; 16(5):1486-93. PubMed ID: 15800130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased L-arginine during peritonitis in ESRD patients on peritoneal dialysis.
    Suh H; Wadhwa NK; Peresleni T; McNurlan M; Garlick P; Goligorsky MS
    Adv Perit Dial; 1997; 13():205-9. PubMed ID: 9360682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.